Exploring the protective effect and molecular mechanism of betulin in Alzheimer's disease based on network pharmacology, molecular docking and experimental validation

Wang,Na; Cui,Jiali; Sun,Ziteng; Chen,Fan; He,Xiaping

doi:10.3892/mmr.2024.13356

Exploring the protective effect and molecular mechanism of betulin in Alzheimer's disease based on network pharmacology, molecular docking and experimental validation

Authors:
- Na Wang
- Jiali Cui
- Ziteng Sun
- Fan Chen
- Xiaping He
View Affiliations

Affiliations: Laboratory of Brain and Cognitive Science, School of Basic Medical Sciences, Dali University, Dali, Yunnan 671003, P.R. China, Yunnan Institute of Materia Medica, Yunnan Province Company Key Laboratory for TCM and Ethnic Drug of New Drug Creation, Kunming, Yunnan 650111, P.R. China, Department of Psychiatry, The Affiliated Mental Health Center of Jiangnan University, Wuxi, Jiangsu 214151, P.R. China
Published online on: October 8, 2024 https://doi.org/10.3892/mmr.2024.13356
Article Number: 232
Copyright: © Wang et al. This is an open access article distributed under the terms of Creative Commons Attribution License.

Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )

Metrics: Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )

Cited By (CrossRef): 0 citations Loading Articles...

Abstract

Alzheimer's disease (AD) is a neurodegenerative disorder that impairs learning and memory, with high rates of mortality. Birch bark has been traditionally used in the treatment of various skin ailments. Betulin (BT) is a key compound of birch bark that exhibits diverse pharmacological benefits and therapeutic potential in AD. However, the therapeutic effects and molecular mechanisms of BT in AD remain unclear. The present study aimed to predict the potential therapeutic targets of BT in the treatment of AD, and to determine the specific underlying molecular mechanisms through network pharmacology analysis and experimental validation. PharmMapper was used to predict the target genes of BT, and four disease databases were searched to screen for AD targets. The intersection targets were identified using the jveen website. Drug‑disease target protein‑protein interaction networks and hub genes were obtained and visualized using the Search Tool for the Retrieval of Interacting Genes/Proteins database and Cytoscape. The Database for Annotation, Visualization and Integrated Discovery was used for Gene Ontology (GO) and Kyoto Encyclopedia of Genes and Genomes (KEGG) enrichment analyses, and AutoDock was used for molecular docking analysis of BT and hub genes. Subsequently, the network‑predicted mechanisms of BT in AD were verified in vitro. A total of 495 BT and 1,386 AD targets were identified, and 120 were identified as potential targets of BT in the treatment of AD. The results of the molecular docking analysis revealed a strong binding affinity between BT and the hub genes. In addition, enrichment analyses of GO and KEGG pathways indicated that the neuroprotective effects of BT mainly involved the ‘PI3K‑Akt signaling pathway’. The results of in vitro experiments demonstrated that pretreatment with BT for 2 h may ameliorate formaldehyde (FA)‑induced cytotoxicity and morphological changes in HT22 cells, and decrease FA‑induced Tau hyperphosphorylation and reactive oxygen species levels. Furthermore, the PI3K/AKT signaling pathway was activated and the expression levels of downstream proteins, namely GSK3β, Bcl‑2 and Bax, were modified following pre‑treatment with BT. Overall, the results of network pharmacology and in vitro analyses revealed that BT may reduce FA‑induced AD‑like pathology by modulating the PI3K/AKT signaling pathway, highlighting it as a potential multi‑target drug for the treatment of AD.

View Figures

View References

1	Knopman DS, Amieva H, Petersen RC, Chételat G, Holtzman DM, Hyman BT, Nixon RA and Jones DT: Alzheimer disease. Nat Rev Dis Primers. 7:332021. View Article : Google Scholar
2	Scheltens P, De Strooper B, Kivipelto M, Holstege H, Chételat G, Teunissen CE, Cummings J and van der Flier WM: Alzheimer's disease. Lancet. 397:1577–1590. 2021. View Article : Google Scholar
3	Rajasekhar K and Govindaraju T: Current progress, challenges and future prospects of diagnostic and therapeutic interventions in Alzheimer's disease. RSC Adv. 8:23780–23804. 2018. View Article : Google Scholar
4	Zhang F, Zhong RJ, Cheng C, Li S and Le WD: New therapeutics beyond amyloid-β and tau for the treatment of Alzheimer's disease. Acta Pharmacol Sin. 42:1382–1389. 2021. View Article : Google Scholar
5	Chen YG: Research progress in the pathogenesis of Alzheimer's disease. Chin Med J (Engl). 131:1618–1624. 2018. View Article : Google Scholar
6	Wightman EL: Potential benefits of phytochemicals against Alzheimer's disease. Proc Nutr Soc. 76:106–112. 2017. View Article : Google Scholar
7	Tuli HS, Sak K, Gupta DS, Kaur G, Aggarwal D, Parashar NC, Choudhary R, Yerer MB, Kaur J, Kumar M, et al: Anti-inflammatory and anticancer properties of birch bark-derived betulin: Recent developments. Plants (Basel). 10:26632021.
8	Buko V, Kuzmitskaya I, Kirko S, Belonovskaya E, Naruta E, Lukivskaya O, Shlyahtun A, Ilyich T, Zakreska A and Zavodnik I: Betulin attenuated liver damage by prevention of hepatic mitochondrial dysfunction in rats with alcoholic steatohepatitis. Physiol Int. 106:323–334. 2019. View Article : Google Scholar
9	Cho N, Kim HW, Lee HK, Jeon BJ and Sung SH: Ameliorative effect of betulin from Betula platyphylla bark on scopolamine-induced amnesic mice. Biosci Biotechnol Biochem. 80:166–171. 2016. View Article : Google Scholar
10	Farzan M, Farzan M, Shahrani M, Navabi SP, Vardanjani HR, Amini-Khoei H and Shabani S: Neuroprotective properties of Betulin, Betulinic acid, and Ursolic acid as triterpenoids derivatives: A comprehensive review of mechanistic studies. Nutr Neurosci. 27:223–240. 2024. View Article : Google Scholar
11	Tsai CW, Tsai RT, Liu SP, Chen CS, Tsai MC, Chien SH, Hung HS, Lin SZ, Shyu WC and Fu RH: Neuroprotective effects of betulin in pharmacological and transgenic caenorhabditis elegans models of parkinson's disease. Cell Transplant. 26:1903–1918. 2017. View Article : Google Scholar
12	Ma C and Long H: Protective effect of betulin on cognitive decline in streptozotocin (STZ)-induced diabetic rats. Neurotoxicology. 57:104–111. 2016. View Article : Google Scholar
13	Liu Q, Liu JP, Mei JH, Li SJ, Shi LQ, Lin ZH, Xie BY, Sun WG, Wang ZY, Yang XL, et al: Betulin isolated from Pyrola incarnata Fisch. inhibited lipopolysaccharide (LPS)-induced neuroinflammation with the guidance of computer-aided drug design. Bioorg Med Chem Lett. 30:1271932020. View Article : Google Scholar
14	Nogales C, Mamdouh ZM, List M, Kiel C, Casas AI and Schmidt H: Network pharmacology: Curing causal mechanisms instead of treating symptoms. Trends Pharmacol Sci. 43:136–150. 2022. View Article : Google Scholar
15	Kim S, Chen J, Cheng T, Gindulyte A, He J, He S, Li Q, Shoemaker BA, Thiessen PA, Yu B, et al: PubChem 2023 update. Nucleic Acids Res. 51:D1373–D1380. 2023. View Article : Google Scholar
16	Wang X, Shen Y, Wang S, Li S, Zhang W, Liu X, Lai L, Pei J and Li H: PharmMapper 2017 update: A web server for potential drug target identification with a comprehensive target pharmacophore database. Nucleic Acids Res. 45:W356–W360. 2017. View Article : Google Scholar
17	UniProt Consortium: UniProt: The universal protein knowledgebase in 2023. Nucleic Acids Res. 51:D523–D531. 2023. View Article : Google Scholar
18	Stelzer G, Rosen N, Plaschkes I, Zimmerman S, Twik M, Fishilevich S, Stein TI, Nudel R, Lieder I, Mazor Y, et al: The genecards suite: From gene data mining to disease genome sequence analyses. Curr Protoc Bioinformatics. 54:1.30.31–31.30.33. 2016. View Article : Google Scholar
19	Pinero J, Ramirez-Anguita JM, Sauch-Pitarch J, Ronzano F, Centeno E, Sanz F and Furlong LI: The DisGeNET knowledge platform for disease genomics: 2019 update. Nucleic Acids Res. 48:D845–D855. 2020.
20	Davis AP, Wiegers TC, Wiegers J, Wyatt B, Johnson RJ, Sciaky D, Barkalow F, Strong M, Planchart A and Mattingly CJ: CTD tetramers: A new online tool that computationally links curated chemicals, genes, phenotypes, and diseases to inform molecular mechanisms for environmental health. Toxicol Sci. 195:155–168. 2023. View Article : Google Scholar
21	Amberger JS and Hamosh A: Searching online mendelian inheritance in man (OMIM): A knowledgebase of human genes and genetic phenotypes. Curr Protoc Bioinformatics. 58:1.2.1–1.2.12. 2017. View Article : Google Scholar
22	Bardou P, Mariette J, Escudié F, Djemiel C and Klopp C: Jvenn: An interactive Venn diagram viewer. BMC Bioinformatics. 15:2932014. View Article : Google Scholar
23	Szklarczyk D, Kirsch R, Koutrouli M, Nastou K, Mehryary F, Hachilif R, Gable AL, Fang T, Doncheva NT, Pyysalo S, et al: The STRING database in 2023: Protein-protein association networks and functional enrichment analyses for any sequenced genome of interest. Nucleic Acids Res. 51:D638–D646. 2023. View Article : Google Scholar
24	Shannon P, Markiel A, Ozier O, Baliga NS, Wang JT, Ramage D, Amin N, Schwikowski B and Ideker T: Cytoscape: A software environment for integrated models of biomolecular interaction networks. Genome Res. 13:2498–2504. 2003. View Article : Google Scholar
25	Chin CH, Chen SH, Wu HH, Ho CW, Ko MT and Lin CY: cytoHubba: Identifying hub objects and sub-networks from complex interactome. BMC Syst Biol. 4:S112014. View Article : Google Scholar
26	Sherman BT, Hao M, Qiu J, Jiao X, Baseler MW, Lane HC, Imamichi T and Chang W: DAVID: A web server for functional enrichment analysis and functional annotation of gene lists (2021 update). Nucleic Acids Res. 50:W216–W221. 2022. View Article : Google Scholar
27	Shen W, Song Z, Zhong X, Huang M, Shen D, Gao P, Qian X, Wang M, He X, Wang T, et al: Sangerbox: A comprehensive, interaction-friendly clinical bioinformatics analysis platform. Imeta. 1:e362022. View Article : Google Scholar
28	Berman HM, Battistuz T, Bhat TN, Bluhm WF, Bourne PE, Burkhardt K, Feng Z, Gilliland GL, Iype L, Jain S, et al: The protein data bank. Acta Crystallogr D Biol Crystallogr. 28:235–242. 2000.
29	Ru J, Li P, Wang J, Zhou W, Li B, Huang C, Li P, Guo Z, Tao W, Yang Y, et al: TCMSP: A database of systems pharmacology for drug discovery from herbal medicines. J Cheminform. 6:132014. View Article : Google Scholar
30	Seeliger D and de Groot BL: Ligand docking and binding site analysis with PyMOL and Autodock/Vina. J Comput Aided Mol Des. 24:417–422. 2010. View Article : Google Scholar
31	Goodsell DS and Olson AJ: Automated docking of substrates to proteins by simulated annealing. Proteins. 8:195–202. 1990. View Article : Google Scholar
32	Wang Z, Sun H, Yao X, Li D, Xu L, Li Y, Tian S and Hou T: Comprehensive evaluation of ten docking programs on a diverse set of protein-ligand complexes: The prediction accuracy of sampling power and scoring power. Phys Chem Chem Phys. 18:12964–12975. 2016. View Article : Google Scholar
33	Chen F, Wang N, Tian X, Su J, Qin Y, He R and He X: The protective effect of mangiferin on formaldehyde-induced HT22 cell damage and cognitive impairment. Pharmaceutics. 15:15682023. View Article : Google Scholar
34	Buttrick GJ and Wakefield JG: PI3-K and GSK-3: Akt-ing together with microtubules. Cell Cycle. 7:2621–2625. 2008. View Article : Google Scholar
35	Pinzi L and Rastelli G: Molecular docking: Shifting paradigms in drug discovery. Int J Mol Sci. 20:43312019. View Article : Google Scholar
36	Liu Y, Shi C, He Z, Zhu F, Wang M, He R, Zhao C, Shi X, Zhou M, Pan S, et al: Inhibition of PI3K/AKT signaling via ROS regulation is involved in Rhein-induced apoptosis and enhancement of oxaliplatin sensitivity in pancreatic cancer cells. Int J Biol Sci. 17:589–602. 2021. View Article : Google Scholar
37	Li H, Deng W, Yang J, Lin Y, Zhang S, Liang Z, Chen J, Hu M, Liu T, Mo G, et al: Corylifol A suppresses osteoclastogenesis and alleviates ovariectomy-induced bone loss via attenuating ROS production and impairing mitochondrial function. Biomed Pharmacother. 171:1161662024. View Article : Google Scholar
38	Zang G, Fang L, Chen L and Wang C: Ameliorative effect of nicergoline on cognitive function through the PI3K/AKT signaling pathway in mouse models of Alzheimer's disease. Mol Med Rep. 17:7293–7300. 2018.
39	Rates SM: Plants as source of drugs. Toxicon. 39:603–613. 2001. View Article : Google Scholar
40	Raskin I, Ribnicky DM, Komarnytsky S, Ilic N, Poulev A, Borisjuk N, Brinker A, Moreno DA, Ripoll C, Yakoby N, et al: Plants and human health in the twenty-first century. Trends Biotechnol. 20:522–531. 2002. View Article : Google Scholar
41	Matsuda H, Ishikado A, Nishida N, Ninomiya K, Fujiwara H, Kobayashi Y and Yoshikawa M: Hepatoprotective, superoxide scavenging, and antioxidative activities of aromatic constituents from the bark of Betula platyphylla var. japonica. Bioorg Med Chem Lett. 8:2939–2944. 1998. View Article : Google Scholar
42	Huh JE, Hong JM, Baek YH, Lee JD, Choi DY and Park DS: Anti-inflammatory and anti-nociceptive effect of Betula platyphylla var. japonica in human interleukin-1β-stimulated fibroblast-like synoviocytes and in experimental animal models. J Ethnopharmacol. 135:126–134. 2011. View Article : Google Scholar
43	Hopkins AL: Network pharmacology: The next paradigm in drug discovery. Nat Chem Biol. 4:682–690. 2008. View Article : Google Scholar
44	Sayas CL and Avila J: GSK-3 and tau: A key duet in Alzheimer's disease. Cells. 10:7212021. View Article : Google Scholar
45	He X, Li Z, Rizak JD, Wu S, Wang Z, He R, Su M, Qin D, Wang J and Hu X: Resveratrol attenuates formaldehyde induced hyperphosphorylation of tau protein and cytotoxicity in N2a cells. Front Neurosci. 10:5982016.
46	Long HZ, Cheng Y, Zhou ZW, Luo HY, Wen DD and Gao LC: PI3K/AKT signal pathway: A target of natural products in the prevention and treatment of Alzheimer's disease and parkinson's disease. Front Pharmacol. 12:6486362021. View Article : Google Scholar
47	Beurel E, Grieco SF and Jope RS: Glycogen synthase kinase-3 (GSK3): Regulation, actions, and diseases. Pharmacol Ther. 148:114–131. 2015. View Article : Google Scholar
48	Plattner F, Angelo M and Giese KP: The roles of cyclin-dependent kinase 5 and glycogen synthase kinase 3 in tau hyperphosphorylation. J Biol Chem. 281:25457–25465. 2006. View Article : Google Scholar
49	Qu ZS, Li L, Sun XJ, Zhao YW, Zhang J, Geng Z, Fu JL and Ren QG: Glycogen synthase kinase-3 regulates production of amyloid-β peptides and tau phosphorylation in diabetic rat brain. ScientificWorldJournal. 2014:8781232014. View Article : Google Scholar
50	Gabbouj S, Ryhänen S, Marttinen M, Wittrahm R, Takalo M, Kemppainen S, Martiskainen H, Tanila H, Haapasalo A, Hiltunen M and Natunen T: Altered insulin signaling in alzheimer's disease brain-special emphasis on PI3K-Akt pathway. Front Neurosci. 13:6292019. View Article : Google Scholar
51	Steen E, Terry BM, Rivera EJ, Cannon JL, Neely TR, Tavares R, Xu XJ, Wands JR and de la Monte SM: Impaired insulin and insulin-like growth factor expression and signaling mechanisms in Alzheimer's disease-is this type 3 diabetes? J Alzheimers Dis. 7:63–80. 2005. View Article : Google Scholar
52	Tulpule K and Dringen R: Formaldehyde in brain: An overlooked player in neurodegeneration? J Neurochem. 127:7–21. 2013. View Article : Google Scholar
53	Liu X, Zhang Y, Wu R, Ye M, Zhao Y, Kang J, Ma P, Li J and Yang X: Acute formaldehyde exposure induced early Alzheimer-like changes in mouse brain. Toxicol Mech Methods. 28:95–104. 2018. View Article : Google Scholar
54	de Souza MT, de Campos Buzzi F, Filho VC, Hess S, Monache FD and Niero R: Phytochemical and antinociceptive properties of Matayba elaeagnoides Radlk. barks. Z Naturforsch C J Biosci. 62:550–554. 2007. View Article : Google Scholar
55	Offen D, Elkon H and Melamed E: Apoptosis as a general cell death pathway in neurodegenerative diseases. J Neural Transm Suppl. 2000:153–166. 2000.
56	Gyparaki MT, Arab A, Sorokina EM, Santiago-Ruiz AN, Bohrer CH, Xiao J and Lakadamyali M: Tau forms oligomeric complexes on microtubules that are distinct from tau aggregates. Proc Natl Acad Sci USA. 118:e20214611182021. View Article : Google Scholar
57	Karikari TK, Pascoal TA, Ashton NJ, Janelidze S, Benedet AL, Rodriguez JL, Chamoun M, Savard M, Kang MS, Therriault J, et al: Blood phosphorylated tau 181 as a biomarker for Alzheimer's disease: A diagnostic performance and prediction modelling study using data from four prospective cohorts. Lancet Neurol. 19:422–433. 2020. View Article : Google Scholar
58	Ci X, Zhou J, Lv H, Yu Q, Peng L and Hua S: Betulin exhibits anti-inflammatory activity in LPS-stimulated macrophages and endotoxin-shocked mice through an AMPK/AKT/Nrf2-dependent mechanism. Cell Death Dis. 8:e27982017. View Article : Google Scholar
59	Yang Q, Fei Z and Huang C: Betulin terpenoid targets OVCAR-3 human ovarian carcinoma cells by inducing mitochondrial mediated apoptosis, G2/M phase cell cycle arrest, inhibition of cell migration and invasion and modulating mTOR/PI3K/AKT signalling pathway. Cell Mol Biol (Noisy-le-grand). 67:14–19. 2021. View Article : Google Scholar
60	Han YH, Mun JG, Jeon HD, Kee JY and Hong SH: Betulin inhibits lung metastasis by inducing cell cycle arrest, autophagy, and apoptosis of metastatic colorectal cancer cells. Nutrients. 12:662019. View Article : Google Scholar
61	Jin H, Wang M, Wang J, Cao H, Niu W and Du L: Paeonol attenuates isoflurane anesthesia-induced hippocampal neurotoxicity via modulation of JNK/ERK/P38MAPK pathway and regulates histone acetylation in neonatal rat. J Matern Fetal Neonatal Med. 33:81–91. 2020. View Article : Google Scholar
62	Korsmeyer SJ, Shutter JR, Veis DJ, Merry DE and Oltvai ZN: Bcl-2/Bax: A rheostat that regulates an anti-oxidant pathway and cell death. Semin Cancer Biol. 4:327–332. 1993.
63	Chen KY, Hsu WL, Hsu SW, Chen CH, Hong KT, Tsai CW, Chang WS, Chen CC, Pei JS, Lee HT and Bau DT: Involvement of mitochondrial damage and oxidative stress in apoptosis induced by betulin plus arsenic trioxide in neuroblastoma cells. Anticancer Res. 43:2467–2476. 2023. View Article : Google Scholar
64	Yang K, Chen Z, Gao J, Shi W, Li L, Jiang S, Hu H, Liu Z, Xu D and Wu L: The key roles of GSK-3β in regulating mitochondrial activity. Cell Physiol Biochem. 44:1445–1459. 2017. View Article : Google Scholar
65	Chen K, Xue R, Geng Y and Zhang S: Galangin inhibited ferroptosis through activation of the PI3K/AKT pathway in vitro and in vivo. FASEB J. 36:e225692022. View Article : Google Scholar
66	Dong L, Du H, Zhang M, Xu H, Pu X, Chen Q, Luo R, Hu Y, Wang Y, Tu H, et al: Anti-inflammatory effect of Rhein on ulcerative colitis via inhibiting PI3K/Akt/mTOR signaling pathway and regulating gut microbiota. Phytother Res. 36:2081–2094. 2022. View Article : Google Scholar
67	Yang S, Xie Z, Pei T, Zeng Y, Xiong Q, Wei H, Wang Y and Cheng W: Salidroside attenuates neuronal ferroptosis by activating the Nrf2/HO1 signaling pathway in Aβ(1–42)-induced Alzheimer's disease mice and glutamate-injured HT22 cells. Chin Med. 17:822022. View Article : Google Scholar
68	Xiong Y, Ruan YT, Zhao J, Yang YW, Chen LP, Mai YR, Yu Q, Cao ZY, Liu FF, Liao W and Liu J: Magnesium-L-threonate exhibited a neuroprotective effect against oxidative stress damage in HT22 cells and Alzheimer's disease mouse model. World J Psychiatry. 12:410–424. 2022. View Article : Google Scholar